BLOCKCHAIN-ENABLED QUALITY BY DESIGN SYSTEM FOR CLINICAL TRIALS

Clicks: 6
ID: 283854
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #288 of 309 articles by views in Frontiers in pharmacology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 309 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
In this paper, blockchain technology is utilized as a distributed data management system and integrated with the Quality by Design (QbD) systematic approach to enhance the quality of clinical trials. This integration aims to boost data integrity within QbD activities and promote participant safety. First, a blockchain-enabled QbD architecture is proposed, and the interactions among its enablers and peers are described. Then, a prototype of the proposed architecture is developed, and data from a pilot trial are used to validate its applicability. The results demonstrate that the proposed architecture is efficient and feasible for adoption in clinical trials. With the successful development of this architecture, it shows promise in enabling effective data integration and knowledge management to improve participant safety.
Reference Key
imported_1760285520_68ebd350a8030 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Hariry, Reza Ebrahimi
Journal Frontiers in pharmacology
Year Year not found
DOI
10.3389/fmed.2025.1546897
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.